FDA approval announcements: Attention-grabbing or event-day misspecification?

The attention-grabbing hypothesis has been offered as a behavioural explanation for post-event abnormal returns for FDA drug approval announcements for NYSE listed firms. We show that when event-day mis-specification is accounted for, the market reaction is centred on the event-day and that the incr...

Full description

Saved in:
Bibliographic details
Volume: 170
Main Author: Hamill, Philip A
Hutchinson, Mark
Nguyen, Quang Minh Nhi
Mulcahy, Mark
Format: Journal Article
Language: English
Zielgruppe: Academic
Place of publication: LAUSANNE Elsevier B.V 01.09.2018
ELSEVIER SCIENCE SA
published in: Economics letters Vol. 170; pp. 171 - 174
ORCID: 0000-0002-2399-6184
0000-0002-2390-1667
0000-0002-1201-646X
Data of publication: September 2018
ISSN: 0165-1765
1873-7374
EISSN: 1873-7374
Discipline: Economics
Subjects:
FDA
FDA
G14
O31
L11
G18
Online Access: available in Bonn?
Database: Web of Knowledge
Social Sciences Citation Index
Web of Science
Web of Science - Social Sciences Citation Index – 2018
CrossRef
Academic OneFile (A&I only)
Database information Databases - DBIS